Molecular recognition of ITIM/ITSM domains with SHP2 and their allosteric effect
Yan Cheng,Weiwei Ouyang,ling liu,Lingkai Tang,Zhigang Zhang,Xinru Yue,Li Liang,Jianping Hu,Ting Luo
DOI: https://doi.org/10.1039/d3cp03923d
IF: 3.3
2023-12-06
Physical Chemistry Chemical Physics
Abstract:The Src homology-2 (SHP2) is a non-receptor protein tyrosine phosphatase, composed of N-SH2, C-SH2, and PTP domains, which are widely expressed in various cells. SHP2 regulates the immune response through the PD-1 pathway in T cells. However, the activation mechanism and allosteric effects of SHP2 remain unclear, hindering the development of small molecule inhibitors based on its structure. In this work, full-length SHP2 was first obtained by homology modeling, followed by the creation of its complex model with the ITIM/ITSM peptide (i.e., PD-1 intracellular part) using molecular docking experiments. Molecular recognition and conformational changes of inactive/active SHP2 with the ITIM/ITSM peptide were compared based on long-time MD simulations. With the binding of the ITIM/ITSM peptide, the N-SH2 domain moves closer to the C-SH2 domain through a large conformational change, resulting in the complete exposure of the enzyme active site in the PTP domain. The Binding free energy calculations show that SHP2 exhibits a lower affinity with the phosphorylated ITIM/ITSM peptide (i.e., SHP2*_IIP) than that with the non-phosphorylated one (i.e., SHP2_IIP), due to the fact that the latter's N-SH2 conformation prefers α-state. According to the superimposition of representative snapshots, the inactive SHP2 tended to change into active conformation under the recognition by the ITIM/ITSM peptide. Given structural lack of full-length SHP2 and its complexes with ligands, the established SHP2*_IIP model provides theoretical guidance for subsequent molecular design of novel anticancer drugs.
chemistry, physical,physics, atomic, molecular & chemical